Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Download in electronic PDF format for $75
Abstract: Transdermal testosterone has been used for years to treat patients with low testosterone symptoms. Clinically, we have monitored patients to evaluate results of testosterone absorption via blood serum concentrations. The data on multiple time points to determine trough and peak concentrations is lacking in the literature. In this case study, we demonstrate the absorption of testosterone cream via scrotal delivery. The data suggests that after application therapeutic levels are reached with concentrations of (1204.7 ng/dL) within two hours. Additionally, consistent concentrations (1320.6 ng/dL) remain beyond six hours. To our knowledge, this is the first study to collect and measure multiple time points for testosterone via transdermal delivery. The research indicates that testosterone via transdermal delivery is an excellent method to achieve therapeutic concentrations of testosterone. Most importantly, the patient’s symptoms resolved without side effects.
Related Keywords:
testosterone cream, scrotal delivery, transdermal administration, case study, topical testosterone cream, low testosterone symptoms, decreased libido, erectile dysfunction, lethary, loss of lean body mass, weight gain
Related Categories:
CASE REPORTS, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, UROLOGY/URINARY TRACT
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Needham Shawn, Needham Shane
|
Nov/Dec 2018
Pg. 466-468
|
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream
Lehman Paul A, Raney Sam G
|
May/Jun 2012
Pg. 248-252
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
|
May/Jun 2017
Pg. 238
|
Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 464
|
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
|
Jul/Aug 2021
Pg. 336-343
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
|
Sep/Oct 2023
Pg. 358-360
|
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Biundo Bruce
|
Jul/Aug 2009
Pg. 276-279
|
Hormone Treatment Options for Males: What to do for Men with Low Testosterone
Biundo Bruce
|
Jan/Feb 2024
Pg. 28-32
|
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L, York Anne E
|
Jul/Aug 2019
Pg. 325-339
|
Case Report: Testosterone Supplementation in a Vasectomy Patient
Jagodzinski Pat
|
Mar/Apr 1999
Pg. 101
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
|
Jul/Aug 2009
Pg. 314-317
|
Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John, DollbaumCharles M
|
Mar/Apr 2011
Pg. 102-112
|
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Mason Dave
|
Jul/Aug 2002
Pg. 255-256
|
Testosterone-Menthol Eutectic Ointment (2% Testosterone)
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 137
|
Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 151
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Return to Top |